MARKETVOLUME®

www.MarketVolume.com

QUEST DIAGNOSTICS (Stock Symbol: DGX)

DGX- Stock Profile


     
Company Name:QUEST DIAGNOSTICS
Stock Ticker (Symbol):DGX
Traded Exchange:New York Stock Exchange
Average Traded Price:$59.98
Average Daily Traded Volume:1,393,200
Started to Trade on:Friday, July 01, 2011

QUEST DIAGNOSTICS Profile

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It offers patients and physicians the access to diagnostic testing services through its network of laboratories and patient service centers; and interpretive consultation services. The company provides commercial clinical testing services, including routine clinical testing for blood chemistries, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, routine microbiology testing, prescription drug monitoring, alcohol and other substance-abuse tests, and allergy tests; gene-based and esoteric testing; and anatomic pathology services, as well as risk assessment services for the life insurance industry. It also develops and integrates clinical connectivity and data management solutions for healthcare organizations, physicians, and clinicians through its Care360 suite of products; and offers Centergy Data Exchange and the ChartMaxx electronic document management system to hospitals. In addition, the company provides central laboratory testing services in connection with clinical research trials on new drugs, vaccines, and medical devices; and clinical testing to employers for the detection of employee use of drugs-of-abuse. Further, it develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including HerpeSelect ELISA tests that detect patient antibodies to certain types of herpes simplex virus, and sells to academic medical centers, hospitals, and commercial laboratories; White Blood Cell Analyzer for performing whole-blood test on finger-stick samples; and InSure fecal immunochemical test for screening for colorectal cancer. The company was founded in 1967 and is headquartered in Madison, New Jersey.

Disclaimer | Privacy © 1997-2013 MarketVolume.com. All Rights Reserved. SV1
Charts
Stocks & ETFs
Indexes
Advance Decline
Knowledge Base
Trading Systems
News

© 1997-2014 www.MarketVolume.com. All Rights Reserved.